Visalytics
Visalytics
approved EB-2 (NIW)

Professor, Principal Investigator

Chemical Biology · China · 2025-01-20

Processing Time
438 days
Decision Date
2025-01-20
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop innovative chemical methods for protein synthesis and conjugation. This work aims to advance the understanding of life-sustaining proteins and enable the development of novel therapeutics for major diseases including HIV, type 2 diabetes, and COVID-19.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research on protein synthesis for treating HIV, diabetes, and COVID-19 was recognized as having clear substantial merit and national importance.

2 Well-positioned to Advance the Endeavor Met

The petitioner's 30 publications, 398 citations, and history of prestigious research funding proved they are well-positioned to succeed.

3 Waiver Benefit Met

On balance, the importance of the petitioner's contributions to the field of chemical biology justified a waiver of the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the client's Ph.D. in biomedical sciences and a strong scholarly record including 30 peer-reviewed journal articles and 4 patents. The work earned 398 citations and was supported by funding from the German Research Foundation and the National Natural Science Foundation of China. The case successfully satisfied all three prongs of the Dhanasar framework.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Reference Letters Independent
Grants
Judging Experience
Original Contributions

Similar Cases

Scientist

Biotechnology · Sri Lanka

WeGreened EB-2 (NIW) approved
Ohio 3 days 2024-02-08
The petitioner proposes to continue research on developing new methodologies for engineering and characterizing novel proteins and antibodies. This work aims to further biomedical studies, the biotechnology industry, and healthcare by providing foundations for innovations in therapeutic treatments.
View Case

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Maryland 5 days 2024-03-20
The petitioner proposes to continue her research on developing biomanufacturing processes to produce therapeutic moieties such as biologics, small molecules, and cell and gene therapies. Her work focuses on achieving optimal-quality treatments for diseases including cancer, inflammation, and rare diseases while expanding the availability of top-tier therapies through biomanufacturing innovations.
View Case

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Washington 369 days 2025-02-05
The petitioner proposes to advance computational algorithms and experimental screening techniques to streamline the creation of modular, low-cost, and efficient protein therapeutics. This work focuses on improving the stability and production of drugs like antibodies and insulins to eliminate cold-chain transportation barriers and reduce healthcare costs.
View Case

Research Assistant

Biotechnology · China

WeGreened EB-2 (NIW) approved
Maryland 643 days 2025-07-30
The petitioner proposes to investigate the molecular processes of protein misfolding to advance therapeutic strategies for neurodegenerative disorders, cancer, and diabetes. His work focuses on identifying how aberrant protein structures can be corrected or leveraged to design cost-effective treatment platforms grounded in structural biochemistry.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-20.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 438 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist